VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 115 filers reported holding VBI VACCINES INC in Q3 2020. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $55,697 | -30.0% | 183,818 | -9.6% | 0.00% | – |
| Q4 2022 | $79,542 | -61.4% | 203,379 | -30.4% | 0.00% | – |
| Q3 2022 | $206,000 | -41.0% | 292,199 | -32.3% | 0.00% | – |
| Q2 2022 | $349,000 | -68.9% | 431,498 | -36.2% | 0.00% | -100.0% |
| Q1 2022 | $1,123,000 | -21.8% | 676,516 | +10.2% | 0.00% | 0.0% |
| Q4 2021 | $1,436,000 | -42.5% | 613,878 | -23.5% | 0.00% | -50.0% |
| Q3 2021 | $2,497,000 | -7.7% | 802,946 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $2,704,000 | +10.8% | 807,057 | -1.6% | 0.00% | 0.0% |
| Q1 2021 | $2,441,000 | +18.3% | 820,063 | +1.6% | 0.00% | 0.0% |
| Q4 2020 | $2,064,000 | -4.3% | 807,346 | -3.6% | 0.00% | -33.3% |
| Q3 2020 | $2,156,000 | +358.7% | 837,118 | +377.6% | 0.00% | +200.0% |
| Q2 2020 | $470,000 | +591.2% | 175,268 | +145.0% | 0.00% | – |
| Q1 2020 | $68,000 | -65.3% | 71,525 | -49.6% | 0.00% | – |
| Q4 2019 | $196,000 | – | 141,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |